Status: Recruiting
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
This is a single arm pilot trial of a novel whole-body Magnetic Resonance Imaging paired with artificial intelligence intervention, to evaluate feasibility defined as scan-rescan reliability, and to estimate the positive predictive value of changes in Magnetic Resonance Imaging scans from baseline to 12-month visit using an Artificial Intelligence algorithm, among 15 pediatric patients with neurofibromatosis type 1 at Cedars-Sinai Medical Center.
Participants needed: 15
Trial details
Age: 5-17Biological sex: AllType: InterventionalSponsor: Nicole BacaUpdated: May 7, 2026Locations: 1
Eligibility criteria
Between the ages of 5 and <18 years at the start of study. If subject will turn... [+1]
Requiring sedation for imaging. [+3]